Filing Details

Accession Number:
0001209191-12-022856
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-04-12 13:09:24
Reporting Period:
2012-04-11
Filing Date:
2012-04-12
Accepted Time:
2012-04-12 13:09:24
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
876343 Biotime Inc BTX Biological Products, (No Disgnostic Substances) (2836) 943127919
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1470741 Pedro Lichtinger 10110 Sorrento Valley Road
Suite C
San Diego CA 92121
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares, No Par Value Acquisiton 2012-04-11 6,250 $3.98 6,250 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Shares Option to Purchase Common Shares $5.13 2016-06-30 20,000 20,000 Direct
Common Shares Option to Purchase Common Shares $5.45 2015-08-09 20,000 20,000 Direct
Common Shares Option to Purchase Common Shares $3.45 2014-08-10 20,000 20,000 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2016-06-30 20,000 20,000 Direct
2015-08-09 20,000 20,000 Direct
2014-08-10 20,000 20,000 Direct
Footnotes
  1. The price of $3.976 per share represents a weighted average of prices ranging from $3.975 to $3.98 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
  2. Does not include shares that may be acquired upon the exercise of certain stock options.
  3. 5,000 options became exercisable on September 30, 2011; December 31, 2011; and March 31, 2012. The remaining 5,000 options will become exercisable on June 30, 2012 based upon continued service on the board of directors.
  4. 5,000 options became exercisable on September 30, 2010; December 31, 2010; March 31, 2011; and June 30, 2011.
  5. 5,000 options became exercisable on September 30, 2009; December 31, 2009; March 31, 2010; and June 30, 2010.